Movers in Medicine

Researchers to be honored at ASPHO


 

Several hematology and oncology researchers will receive awards at the 2019 conference of the American Society of Pediatric Hematology/Oncology (ASPHO), which takes place May 1-4.

Dr. Loretta Li, Boston Children's Hospital/Dana-Farber Cancer Institute

Dr. Loretta Li

Loretta Li, MD, of Boston Children’s Hospital/Dana-Farber Cancer Institute, and Akshay Sharma, MBBS, of St. Jude Children’s Research Hospital in Memphis, will receive Young Investigator awards at the conference.

Dr. Akshay Sharma, St. Jude Children's Research Hospital, Memphis, Tenn.

Dr. Akshay Sharma

Dr. Sharma is conducting research investigating the genetic regulation of fetal hemoglobin and developing transplant and gene therapy trials for patients with sickle cell disease. Dr. Li is studying the activity of JAK2 inhibitors, as well as mechanisms of response and resistance to these drugs, in leukemias.

Dr. Elliott Vichinsky, UCSF Benioff Children’s Hospital Oakland (Calif.)

Dr. Elliott Vichinsky

Elliott Vichinsky, MD, of UCSF Benioff Children’s Hospital Oakland in California, will receive ASPHO’s Distinguished Career Award. Dr. Vichinsky has helped implement newborn screening programs for blood diseases, developed techniques to make blood safer for chronically transfused patients, and conducted research that furthered the development of drugs used to treat iron overload.

Dr. Wilbur Lam, Aflac Cancer & Blood Disorders Center/Emory University, Atlanta

Dr. Wilbur Lam

Wilbur Lam, MD, PhD, of Aflac Cancer & Blood Disorders Center/Emory University in Atlanta, has won the Frank A. Oski Memorial Lectureship. He will present “Development and Clinical Translation of Engineered Microsystems for Hematologic Applications” on May 2.

Dr. Lam’s research has focused on using nanomechanical and microfluidic engineering approaches to study blood cells, endothelial cells, and thrombosis. Dr. Lam and his lab have created “microvasculature-on-a-chip” models of blood diseases and a smartphone app that can detect and monitor anemia.

Dr. Kenneth McClain, Texas Children's Hospital/Baylor University, Houston

Dr. Kenneth McClain

Kenneth McClain, MD, PhD, of Texas Children’s Hospital/Baylor University in Houston, has won the 2019 George R. Buchanan Lectureship. Dr. McClain will present “An Oncogene-Driven Orphan Disease: A Short History of Langerhans Cell Histiocytosis” on May 2.

Dr. McClain’s research has focused on Langerhans cell histiocytosis and related disorders. He has served as a founding member and president of the Histiocyte Society, and he organizes yearly events to provide information on Langerhans cell histiocytosis to patients and their families.

Dr. Smita Bhatia, University of Alabama, Birmingham

Dr. Smita Bhatia

Smita Bhatia, MD, of University of Alabama, Birmingham, has won the Childhood Cancer Survivorship Award for Excellence. Her research has focused on health‐related outcomes in cancer survivors and the pathogenesis of these outcomes. Dr. Bhatia has developed models that can identify high-risk cancer survivors and interventions that can reduce complications among cancer survivors.

Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.

Recommended Reading

Proportion of women speaking at medical conferences rises over decade
MDedge Hematology and Oncology
As Sanders officially revives Medicare-for-all, Plan B for Democrats gains traction
MDedge Hematology and Oncology
Negotiating an employment contract? Lawyer up
MDedge Hematology and Oncology
Mortality rates higher in affiliates, compared with top-ranked hospitals
MDedge Hematology and Oncology
Cost gap widens between brand-name, generic drugs
MDedge Hematology and Oncology
CDC clarifies opioid prescribing guidelines in cancer, sickle cell disease
MDedge Hematology and Oncology
Direct-to-consumer genetic testing fraught with validity concerns
MDedge Hematology and Oncology
MAT access helps address opioid use disorder
MDedge Hematology and Oncology
How to incorporate the gender wage gap into contract negotiations
MDedge Hematology and Oncology
CMS plan will incentivize generic drug use
MDedge Hematology and Oncology